NK Max, Immuno-oncology Theme Rises 7.04%

On the 10th, the immuno-oncology theme rose 3.19% compared to the previous day, showing strength, while NKMAX, a related stock drawing attention, surged 7.04% compared to the previous day. NKMAX is known as a manufacturer of basic pharmaceutical substances and biological products.

[Graph] Price Fluctuations of Major Stocks in the Immuno-Oncology Theme



According to the analysis by Thinkpool Robo Algorithm RASSI, NKMAX’s quant financial score was 6.69 points, ranking 14th in quant financial ranking within the immuno-oncology theme. This can be interpreted as NKMAX having relatively low investment attractiveness from a financial perspective. On the other hand, Dong-A ST ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Score within the Theme


※ The quant financial score is the result of the robo algorithm analyzing each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.